MarketInOut Stock Screener Log In | Sign Up
 

Dermapharm Holding SE

VIE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 07/28/2026 15:30
Dermapharm Holding SE stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeVIE
Market Capitalization2,147.59 mln
Float7.04 mln
Earnings Date05/13/2026

EPS

2.68
Solid

P / E

15.35
Moderately valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.64
Likely reliable

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

1.42
Elevated leverage

Business Description

Dermapharm Holding SE is a German pharmaceutical company founded in 1991 that produces and sells a wide range of established branded medicines, health supplements, cosmetics, and medical devices across Europe, the United States, and China. Its product portfolio covers areas such as skin care, heart health, pain relief, women's health, and allergy treatment, sold under well-known brand names including Dekristol, Tromcardin, and Herpotherm. The company also imports original branded pharmaceuticals from other manufacturers, distributing them through its axicorp brand. Dermapharm operates as part of the Themis Beteiligungs-AG group and is headquartered in Grünwald, Germany.

Key Fundamentals

EPS2.68
P/E15.35
ROE21.66
RPS21.72
ROIC9.48
ROA6.66
Interest Cover4.91
EBITDA, mln337
EV / EBITDA9.31
EV / EBIT12.86
Revenue, mln1,168
EV / Revenue2.68

Financial Strength

Altman Z-Score2.31
Piotroski F-Score 8 / 9
Beneish M-Score-2.64
Price to Intrinsic Value0.86
Shiller PE Ratio16.56

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.84% 32 / 100   
1 Month -11.73% 8 / 100   
2 Months -8.02% 19 / 100   
6 Months 17.98% 72 / 100   
1 Year 19.48% 60 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us